"When you need comprehensive healthcare services, close to home, delivered by professionals who combine world-class services with a human touch, Geisinger Medical Center (GMC) is here for you. When you need comprehensive healthcare services, close to home, delivered by professionals who combine world-class services with a human touch, Geisinger Medical Center (GMC) is here for you. Geisinger Medical Center is more than a hospital. It is central Pennsylvania’s most complete healthcare system, offering many services that are not available anywhere else locally. With more than 2,000 healthcare professionals, GMC is the right choice when you need specialized, personalized care."

During the past decade, Geisinger Medical Center conducted 342 clinical trials. In the 10-year time frame, 342 clinical trials started and 250 clinical trials were completed, i.e. on average, 73.1% percent of trials that started reached the finish line to date. In the past 5 years, 112 clinical trials started and 115 clinical trials were completed. i.e. 102.7% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Geisinger Medical Center" #1 sponsor was "National Cancer Institute (NCI)" with 182 trials, followed by "Alliance for Clinical Trials in Oncology" with 88 trials sponsored, "Children's Oncology Group" with 83 trials sponsored, "Geisinger Clinic" with 69 trials sponsored and "Radiation Therapy Oncology Group" with 69 trials sponsored. Other sponsors include 389 different institutions and companies that sponsored additional 177 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Geisinger Medical Center" #1 collaborator was "National Cancer Institute (NCI)" with 378 trials as a collaborator, "NRG Oncology" with 42 trials as a collaborator, "Geisinger Clinic" with 25 trials as a collaborator, "Eastern Cooperative Oncology Group" with 20 trials as a collaborator and "SWOG Cancer Research Network" with 20 trials as a collaborator. Other collaborators include 388 different institutions and companies that were collaborators in the rest 235 trials.

According to Clinical.Site data, the most researched conditions in "Geisinger Medical Center" are "Breast Cancer" (40 trials), "Lymphoma" (23 trials), "Lung Cancer" (22 trials), "Colorectal Cancer" (19 trials) and "Prostate Cancer" (18 trials). Many other conditions were trialed in "Geisinger Medical Center" in a lesser frequency.

Most popular intervention types in "Geisinger Medical Center" are "Drug" (531 trials), "Other" (302 trials), "Biological" (199 trials), "Procedure" (167 trials) and "Radiation" (155 trials). Other intervention types were less common.

The name of intervention was led by "Laboratory Biomarker Analysis" (140 trials), "Quality-of-Life Assessment" (93 trials), "Questionnaire Administration" (59 trials), "radiation therapy" (59 trials) and "Carboplatin" (48 trials). Other intervention names were less common.

The vast majority of trials in "Geisinger Medical Center" are 724 trials for "All" genders, 105 trials for "Female" genders and 32 trials for "Male" genders.

Currently, there are 327 active trials in "Geisinger Medical Center". 2 are not yet recruiting, 133 are recruiting, 183 are Active, not recruiting, and 9 are Enrolling by invitation. In total, there were 452 completed trials in Geisinger Medical Center, 10 suspended trials, and 50 terminated clinical trials to date.

Out of the total trials that were conducted in Geisinger Medical Center, 27 "Phase 1" clinical trials were conducted, 276 "Phase 2" clinical trials and 336 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 19 trials, and there were also 136 trials that are defined as “Not Applicable".